Using a device to control appetite in people with obesity
Determining the Physiological Mechanism Behind Acute ObeEnd Device Exposure on Factors Regulating Appetite
This study tests if a device that sends electrical pulses to a wrist point can help women with obesity control their appetite and support weight loss.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Concordia University, Montreal Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT06487234 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of the ObeEnd device, which uses electrical pulses to stimulate an acupressure point on the wrist, on appetite regulation in individuals with obesity. The trial aims to measure changes in appetite hormones and enzymes after using the device compared to a placebo. Participants will include generally healthy, premenopausal females with a BMI over 30. The goal is to determine if this innovative approach can help normalize appetite and support weight loss efforts.
Who should consider this trial
Good fit: Ideal candidates are generally healthy, premenopausal females with a BMI greater than 30.
Not a fit: Patients with chronic diseases, metabolic conditions, or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this device could provide a non-invasive method to help individuals with obesity manage their appetite and support weight loss.
How similar studies have performed: While the use of electrostimulation for appetite control is a novel approach, similar studies have shown promise in related areas, but this specific method is less tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * People with obesity (BMI\>30kg/m2) * Generally healthy * Premenopausal females Exclusion Criteria: * Past (\<1 year) or present use of nicotine products * History of chronic disease or metabolic conditions * Females who are pregnant, less than 6 months postpartum, or breastfeeding * Diagnosed hepatic disease, renal impairment, uncontrolled hypothyroidism * Use of any medications that may affect study outcomes (e.g. hormone replacement therapy)
Where this trial is running
Montreal, Quebec
- Concordia University — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Sylvia Santosa, PhD, RD — Concordia University, Montreal
- Study coordinator: Sylvia Santosa, PhD
- Email: s.santosa@concordia.ca
- Phone: 514-848-2424
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.